Which assessment finding indicates that the patient is at risk from polypharmacy? (Select all that apply.)

Choice A reason: Multiple pharmacies increase polypharmacy risk; 16 prescriptions across four sources raise chances of duplication or interactions, lacking centralized oversight. Choice B reason: Five hypertension drugs signal polypharmacy; excessive medications for one condition heighten interaction risks, potentially causing adverse effects or toxicity. Choice C reason: Daughter’s help with eyedrops aids compliance; this single-task assistance doesn’t inherently increase drug numbers or polypharmacy-related risks. Choice D reason: Weekly warfarin tests monitor safety; this manages one drug’s effect, not indicating polypharmacy, but rather appropriate therapeutic oversight. Choice E reason: Allergies affect drug choice, not quantity; this doesn’t contribute to polypharmacy, as it’s a sensitivity issue, not a medication count concern.